EP2714909A4 - Procédé de production de protéines du facteur viii par des procédés recombinants - Google Patents

Procédé de production de protéines du facteur viii par des procédés recombinants

Info

Publication number
EP2714909A4
EP2714909A4 EP12796718.0A EP12796718A EP2714909A4 EP 2714909 A4 EP2714909 A4 EP 2714909A4 EP 12796718 A EP12796718 A EP 12796718A EP 2714909 A4 EP2714909 A4 EP 2714909A4
Authority
EP
European Patent Office
Prior art keywords
factor viii
recombinant methods
producing factor
viii proteins
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12796718.0A
Other languages
German (de)
English (en)
Other versions
EP2714909A1 (fr
Inventor
Randal J Kaufman
Steven W Pipe
Michael Griffith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cangene Corp
University of Michigan
Original Assignee
Cangene Corp
University of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/153,040 external-priority patent/US20120028900A1/en
Application filed by Cangene Corp, University of Michigan filed Critical Cangene Corp
Publication of EP2714909A1 publication Critical patent/EP2714909A1/fr
Publication of EP2714909A4 publication Critical patent/EP2714909A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP12796718.0A 2011-06-03 2012-06-01 Procédé de production de protéines du facteur viii par des procédés recombinants Withdrawn EP2714909A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/153,040 US20120028900A1 (en) 2006-06-30 2011-06-03 Method of producing factor viii proteins by recombinant methods
PCT/US2012/040376 WO2012170289A1 (fr) 2011-06-03 2012-06-01 Procédé de production de protéines du facteur viii par des procédés recombinants

Publications (2)

Publication Number Publication Date
EP2714909A1 EP2714909A1 (fr) 2014-04-09
EP2714909A4 true EP2714909A4 (fr) 2014-12-17

Family

ID=47296374

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12796718.0A Withdrawn EP2714909A4 (fr) 2011-06-03 2012-06-01 Procédé de production de protéines du facteur viii par des procédés recombinants

Country Status (3)

Country Link
EP (1) EP2714909A4 (fr)
CA (1) CA2837995A1 (fr)
WO (1) WO2012170289A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20231183T1 (hr) 2013-02-15 2024-01-05 Bioverativ Therapeutics Inc. Optimizirani gen faktora viii
KR102554850B1 (ko) * 2015-02-06 2023-07-13 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 최적화된 인간 응고 인자 viii 유전자 발현 카세트 및 그의 용도
CA2993885A1 (fr) * 2015-08-06 2017-02-09 Glycotope Gmbh Heteromeres comprenant des proteines fusionnees a un domaine d'anticorps
EP3411478B1 (fr) 2016-02-01 2022-06-08 Bioverativ Therapeutics Inc. Gènes du facteur viii optimisés
US11299533B2 (en) 2017-06-23 2022-04-12 Takeda Pharmaceutical Company Limited Purification of factor VIII subspecies
WO2020086686A2 (fr) * 2018-10-23 2020-04-30 The Children's Hospital Of Philadelphia Compositions et procédés de modulation de la fonction du facteur viii
WO2021043757A1 (fr) * 2019-09-02 2021-03-11 Biotest Ag Protéine du facteur viii à demi-vie accrue
EP3785726A1 (fr) * 2019-09-02 2021-03-03 Biotest AG Protéine de facteur viii à demi-vie prolongée
CN117192132B (zh) * 2023-11-03 2024-02-02 庄亚(北京)生物科技有限公司 一种vWF片段残留检测试剂盒及方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008005847A2 (fr) * 2006-06-30 2008-01-10 The Regents Of The University Of Michigan Procédé de production de protéines de type facteur viii par des procédés recombinants

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008005847A2 (fr) * 2006-06-30 2008-01-10 The Regents Of The University Of Michigan Procédé de production de protéines de type facteur viii par des procédés recombinants

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KERRY L. DOORISS ET AL: "Comparison of Factor VIII Transgenes Bioengineered for Improved Expression in Gene Therapy of Hemophilia A", HUMAN GENE THERAPY, vol. 20, no. 5, 1 May 2009 (2009-05-01), pages 465 - 478, XP055136766, ISSN: 1043-0342, DOI: 10.1089/hum.2008.150 *
MIAO HONGZHI Z ET AL: "Bioengineering of coagulation factor VIII for improved secretion", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 103, no. 9, 1 May 2004 (2004-05-01), pages 3412 - 3419, XP002452857, ISSN: 0006-4971, DOI: 10.1182/BLOOD-2003-10-3591 *
N. J. WARD ET AL: "Codon optimization of human factor VIII cDNAs leads to high-level expression", BLOOD, vol. 117, no. 3, 20 January 2011 (2011-01-20), pages 798 - 807, XP055052195, ISSN: 0006-4971, DOI: 10.1182/blood-2010-05-282707 *
See also references of WO2012170289A1 *

Also Published As

Publication number Publication date
EP2714909A1 (fr) 2014-04-09
WO2012170289A1 (fr) 2012-12-13
CA2837995A1 (fr) 2012-12-13

Similar Documents

Publication Publication Date Title
IL282393B (en) Production of heterodimeric proteins
IL263389B (en) A method for the production of modified 5-fluoro-1h-pyrazolopyridines
EP2873677A4 (fr) Procédé de production de dérivé de peptides s'auto-assemblant
EP2714909A4 (fr) Procédé de production de protéines du facteur viii par des procédés recombinants
SG11201504694VA (en) Method for producing a recombinant protein of interest
EP2721017A4 (fr) Procédé de production de béraprost
EP2774982A4 (fr) Procédé de sécrétion et de production de protéines
EP2772546A4 (fr) Procédé de production de sécrétion pour une protéine
SG10201502139XA (en) Method of Producing Recombinant Proteins with Mannose-Terminated N-Glycans
HK1209790A1 (en) Method of producing recombinant iduronate-2-sulfatase -2-
EP2725033A4 (fr) Procédé de production d'une préparation protéique
AP3748A (en) Method of producing hydrocarbons
EP2781601A4 (fr) Procédé pour produire un agrégat insoluble de protéine associée à une maladie neurodégénérative
EP2726652A4 (fr) Procédé de présentation de protéines
EP2695947A4 (fr) Procédé de production de polypeptide recombiné
EP2737065A4 (fr) Procédé de production de protéines
EP2773964A4 (fr) Procédé de détermination de propriétés pharmacologiques de protéines recombinantes
SG11201405721VA (en) Method of producing a recombinant peptide
EP2688913A4 (fr) Production à haut niveau de protéines recombinantes
ZA201306575B (en) Preparation method of new recombinant antibactirial polypeptide medicine
SG11201401540WA (en) Method for synthesizing proteins
EP2653541A4 (fr) Méthode de production de protéines
IL220941A0 (en) Method for producing recombinant virus
ME03515B (fr) Production de protéines hétérodimères
EP2717345A4 (fr) Procédé de production d'un semi-conducteur en protéine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20131216

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CANGENE CORPORATION

Owner name: THE REGENTS OF THE UNIVERSITY OF MICHIGAN

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20141117

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/37 20060101ALI20141111BHEP

Ipc: C07K 14/755 20060101ALI20141111BHEP

Ipc: C12Q 1/68 20060101ALI20141111BHEP

Ipc: A61P 7/04 20060101ALI20141111BHEP

Ipc: C12N 15/12 20060101AFI20141111BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150616